Resveratrol, a polyphenol and a potentially effective therapeutics option for endometriosis, was found as a SIRT1 activator through upregulating NMNAT1 to increase NAD+ (Grant, 2010; Taguchi et al., 2014). This evidence concerns the gene NMNAT1 and endometriosis.